GS

Gaurav Sharma

Active Director Director DIN 08810059
DIN 08810059 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Gaurav Sharma

Data last updated:

Gaurav Sharma is a Director at Shivaxy Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Shivaxy Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (FY 2025).

DIN 08810059
Primary Designation Director
Industry Pharma
First Appointment 27 Jul 2020
Oldest Company Age 6 yrs
Largest company Shivaxy Pharmaceuticals Private Limited · ₹1.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jul 20202020₹1.97 Cr (FY 2025)Active

Board colleagues of Gaurav Sharma

NameDINCompanyDesignation
Kumari Aarti08810058Shivaxy Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shivaxy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gaurav Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Sharma

Gaurav Sharma currently holds 1 directorship: Shivaxy Pharmaceuticals Private Limited (Director, since 27 Jul 2020, revenue ₹1.97 Cr (FY 2025)).

Gaurav Sharma was first appointed on 27 Jul 2020 as Director at Shivaxy Pharmaceuticals Private Limited.

The current boards of Gaurav Sharma's companies include Kumari Aarti (Shivaxy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available